Literature DB >> 7920012

Characterization of antibodies to bacterial double-stranded DNA in the sera of normal human subjects.

M P Bunyard1, D S Pisetsky.   

Abstract

To assess the human antibody response to bacterial double-stranded (ds) DNA, sera from normal human subjects (NHS) were tested by ELISA for binding to highly purified dsDNA from Micrococcus lysodeikticus (MC). Of 38 NHS tested, 19 demonstrated significant activity to MC dsDNA (defined as an OD380 > 1.0 at a 1:100 dilution of serum) without appreciable binding to dsDNA from Escherichia coli or calf thymus. In competition ELISA, antibodies in NHS to MC dsDNA showed equivalent inhibition by MC ssDNA or dsDNA. Antibody specificity was further evaluated by testing the effects of ionic strength on binding. By ELISA, antibodies in NHS had greater binding to MC dsDNA at high ionic strengths than those in systemic lupus erythematosus sera. These results indicate that NHS have antibodies which bind bacterial dsDNA and extend the range of DNA determinants that can be recognized as foreign by the normal immune system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920012     DOI: 10.1159/000236813

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

Review 1.  The response of human B lymphocytes to oligodeoxynucleotides.

Authors:  H Liang; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  The antigenic properties of bacterial DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Antibody responses to DNA in normal immunity and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 4.  Evolving story of autoantibodies in systemic lupus erythematosus.

Authors:  David S Pisetsky
Journal:  J Autoimmun       Date:  2019-12-04       Impact factor: 7.094

Review 5.  Anti-DNA antibodies--quintessential biomarkers of SLE.

Authors:  David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2015-11-19       Impact factor: 20.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.